Related Experiment Video
Updated: Jul 16, 2026

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
Published on: March 20, 2026
Campylobacter reactive arthritis: a systematic review.
Janet E Pope1, Adriana Krizova, Amit X Garg
1Division of Rheumatology, Department of Medicine, The University of Western Ontario, Ontario, Canada. janet.pope@sjhc.london.on.ca
Campylobacter-associated reactive arthritis (ReA) incidence varies widely, potentially affecting 1-5% of infected individuals. Long-term outcomes and chronic ReA impact remain largely unknown.
Area of Science:
- Rheumatology
- Infectious Diseases
- Epidemiology
Background:
- Reactive arthritis (ReA) is a form of spondyloarthropathy.
- Campylobacter infection is a known trigger for ReA.
Purpose of the Study:
- To review the existing literature on the epidemiology of Campylobacter-associated reactive arthritis.
Main Methods:
- A comprehensive literature search was conducted using Medline (PubMed) from 1966 to 2006.
- Keywords included various terms related to reactive arthritis, spondyloarthropathy, and Campylobacter infection epidemiology.
Main Results:
- The incidence of Campylobacter-associated ReA is estimated between 1-5% of infected individuals.
- Annual incidence rates per 100,000 were reported as 4.3 for Campylobacter and 1.3 for Shigella.
- Data on the duration of acute ReA is variable, and the long-term impact of chronic ReA is largely unknown.
Conclusions:
- Wide variations in reported incidence and prevalence are attributed to differences in case ascertainment, diagnostic criteria, and population factors.
- HLA-B27 association and inflammatory back involvement appear uncommon at the population level.
- Long-term sequelae of Campylobacter-associated ReA require further investigation, with an estimated 5% potentially developing chronic or relapsing symptoms.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cross-reactivity
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis II: Pathophysiology